Acrobiosystems Co.,Ltd. (SHE:301080)

Acrobiosystems Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	673.43	632.94	532.8	466.58	376.71	239.78
Other Revenue	12.09	12.09	10.85	7.85	8.28	6.54
Revenue	685.51	645.02	543.65	474.43	384.99	246.32
Revenue Growth (YoY)	24.01%	18.65%	14.59%	23.23%	56.30%	138.47%
Cost of Revenue	105.41	98.24	85.14	59.01	34.27	22.96
Gross Profit	580.11	546.78	458.52	415.42	350.72	223.35
Selling, General & Admin	332.87	321.28	254.64	185.23	115.81	55.83
Research & Development	167.26	161.87	122.22	112.47	59.55	30.65
Other Operating Expenses	3.82	2.68	2.3	0.8	0.73	0.44
Operating Expenses	505.97	487.3	379.85	299.12	177.09	87.72
Operating Income	74.13	59.48	78.67	116.3	173.63	135.64
Interest Expense	-4.99	-3.54	-2.7	-2.95	-1.15	-
Interest & Investment Income	60.95	61.91	60.92	63.25	10.72	0.8
Currency Exchange Gain (Loss)	3.56	3.56	10.87	15.5	1.42	-2.27
Other Non Operating Income (Expenses)	-6.5	-2.82	-2.78	-1.72	-1.06	-1.15
EBT Excluding Unusual Items	127.14	118.58	144.99	190.39	183.56	133.02
Gain (Loss) on Sale of Investments	-1.48	-1.48	0.66	0.62	0.06	0.01
Gain (Loss) on Sale of Assets	-0.35	-0.35	-	0.21	0.28	-0.01
Asset Writedown	0.48	-0	-0.11	-0.76	-0.05	-0
Other Unusual Items	11.02	8.16	15.12	24.52	11.59	0.61
Pretax Income	136.81	124.91	160.67	214.99	195.44	133.63
Income Tax Expense	5.68	4.87	13.12	15.77	22	17.94
Earnings From Continuing Operations	131.14	120.04	147.55	199.21	173.44	115.69
Minority Interest in Earnings	2.6	3.79	6.04	4.52	0.78	0.19
Net Income	133.74	123.83	153.59	203.73	174.21	115.88
Net Income to Common	133.74	123.83	153.59	203.73	174.21	115.88
Net Income Growth	-3.93%	-19.38%	-24.61%	16.95%	50.34%	943.79%
Shares Outstanding (Basic)	120	120	120	120	95	90
Shares Outstanding (Diluted)	120	120	120	120	95	90
Shares Change (YoY)	0.11%	0.02%	-0.03%	26.34%	5.56%	394.51%
EPS (Basic)	1.11	1.03	1.28	1.70	1.83	1.29
EPS (Diluted)	1.11	1.03	1.28	1.70	1.83	1.29
EPS Growth	-4.04%	-19.39%	-24.59%	-7.44%	42.42%	111.07%
Free Cash Flow	-91.83	-82.56	-17.49	-82.1	76.31	81.52
Free Cash Flow Per Share	-0.77	-0.69	-0.15	-0.68	0.80	0.91
Dividend Per Share	0.700	0.700	0.900	1.000	1.000	-
Dividend Growth	-22.22%	-22.22%	-10.00%	-	-	-
Gross Margin	84.62%	84.77%	84.34%	87.56%	91.10%	90.68%
Operating Margin	10.81%	9.22%	14.47%	24.51%	45.10%	55.07%
Profit Margin	19.51%	19.20%	28.25%	42.94%	45.25%	47.05%
Free Cash Flow Margin	-13.40%	-12.80%	-3.22%	-17.30%	19.82%	33.09%
EBITDA	104.74	88.28	100.27	131.94	182.24	141.28
EBITDA Margin	15.28%	13.69%	18.44%	27.81%	47.34%	57.36%
D&A For EBITDA	30.61	28.81	21.6	15.64	8.61	5.64
EBIT	74.13	59.48	78.67	116.3	173.63	135.64
EBIT Margin	10.81%	9.22%	14.47%	24.51%	45.10%	55.07%
Effective Tax Rate	4.15%	3.90%	8.16%	7.34%	11.26%	13.42%
Revenue as Reported	685.51	645.02	543.65	474.43	384.99	246.32
Advertising Expenses	-	53.69	52	35.84	32.85	13.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.